학술논문

A PHASE 1 TRIAL OF IMMUNORADIOTHERAPY WITH THE IDO ENZYME INHIBITOR (BMS-986205) AND NIVOLUMAB IN PATIENTS WITH NEWLY DIAGNOSED MGMT PROMOTER UNMETHYLATED IDHWT GLIOBLASTOMA
Document Type
Journal
Source
NEURO-ONCOLOGY; NOV 2021, 23 p51-p52, 2p. Supplement: 6
Subject
Language
English
ISSN
15235866